Home Ten63 Therapeutics

Ten63 Therapeutics

In operation
Series A
Targeted Drug Developer
Basic
Enterprise Profile

Basic Information

Ten63 Therapeutics is a company that combines generative AI and physics-based models to develop targeted "undruggable" potential cancer therapies. Ten63 Therapeutics is leveraging its BEYOND generative cheminformatics platform to develop first-in-class and best-in-class treatments. The company is advancing its internal pipeline focused on oncology while pursuing options and strategic partnerships for multiple indications.
Ten63 Therapeutics, Inc
NorthCarolina,United States of America
less than 15 people
January 01, 2017
info@gavilanbio.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Targeted Technology
Concept
Tumor Therapeutic Products
Application Scenarios
Targeted drugs Innovative Drugs